Kenya has been picked among nine countries for the trials of the new injectable HIV prevention drug that has been rolled out ...

Kenya has been selected as one of the 9 early adopter countries for the rollout of Lenacapavir (LEN), a long-acting ...

Overall, HIV prevalence in Kenya fell from 14 percent in the mid-’90s to 5 percent in 2006, and AIDS-related deaths decreased by 29 percent between 2002 and 2007.

In 2015, almost half of the new HIV infections in Kenya were among girls and young women aged 15 to 24 years. Their vulnerability to HIV infection is due to limited knowledge on HIV/AIDS.

Kenya is among nine African countries selected to introduce Lenacapavir, a groundbreaking long-acting injectable HIV ...